Publicité
Publicité
ENSC
Ensysce Biosciences, Inc. Common Stock
1.01
USDSponsorisé
-0.05
-4.81%
09 janv., 15:59 UTC -5
Fermé
Après-marché
1.00
0.00
-0.40%
ENSC Rapports sur les bénéfices
Ratio de surprise positive
ENSC a dépassé 11 des 16 dernières estimations.
69%
Prochain rapport
Date du prochain rapport
09 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$510.00K
/-$1.28
Variation implicite de Q3 25 (Revenue/ EPS)
+3.45%
/-0.78%
Variation implicite de Q4 24 (Revenue/ EPS)
-60.89%
/-55.86%
Ensysce Biosciences, Inc. Common Stock earnings per share and revenue
On 14 nov. 2025, ENSC reported earnings of -1.29 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -46.21% surprise. Revenue reached 493.00 mille, compared to an expected 714.00 mille, with a -30.95% difference. The market reacted with a -4.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -1.28 USD, with revenue projected to reach 510.00 mille USD, implying an baisse of -0.78% EPS, and hausse of 3.45% in Revenue from the last quarter.
FAQ
What were Ensysce Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ensysce Biosciences, Inc. Common Stock reported EPS of -$1.29, missing estimates by -46.21%, and revenue of $493.00K, -30.95% below expectations.
How did the market react to Ensysce Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.85%, changed from $2.06 before the earnings release to $1.96 the day after.
When is Ensysce Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 mars 2026.
What are the forecasts for Ensysce Biosciences, Inc. Common Stock's next earnings report?
Based on 3
analystes, Ensysce Biosciences, Inc. Common Stock is expected to report EPS of -$1.28 and revenue of $510.00K for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité